Status:
UNKNOWN
CONNECT DES Registrty
Lead Sponsor:
Yonsei University
Conditions:
Stent Thrombosis
Coronary Artery Disease
Eligibility:
All Genders
20+ years
Brief Summary
To date, drug-eluting stents (DES) have become the standard of care in daily practice for the treatment of ischemic heart disease, by overcoming the risk of in-stent restenosis, a major issue raised i...
Detailed Description
According to stringent policy of NHIS database to protect personal information, information regarding type of DES including the thickness of strut, eluted drugs, type of polymer, generation of the DES...
Eligibility Criteria
Inclusion
- Patients who were over 20 years old at the implantation of DES and treated with DES between 1-January-2005 and 31-December-2016
Exclusion
- Patients who died within 1 week after DES implantation
Key Trial Info
Start Date :
August 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
350000 Patients enrolled
Trial Details
Trial ID
NCT04715594
Start Date
August 11 2019
End Date
December 1 2021
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hong Myeong-Ki
Seoul, South Korea